rs146637219
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PM2BP4_StrongBP6_Very_StrongBS1
The NM_024753.5(TTC21B):āc.2161A>Cā(p.Asn721His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000218 in 1,613,014 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_024753.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTC21B | NM_024753.5 | c.2161A>C | p.Asn721His | missense_variant | 16/29 | ENST00000243344.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTC21B | ENST00000243344.8 | c.2161A>C | p.Asn721His | missense_variant | 16/29 | 1 | NM_024753.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00116 AC: 177AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000343 AC: 86AN: 250766Hom.: 0 AF XY: 0.000170 AC XY: 23AN XY: 135634
GnomAD4 exome AF: 0.000120 AC: 175AN: 1460740Hom.: 1 Cov.: 31 AF XY: 0.0000826 AC XY: 60AN XY: 726780
GnomAD4 genome AF: 0.00116 AC: 176AN: 152274Hom.: 0 Cov.: 32 AF XY: 0.00107 AC XY: 80AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Uncertain significance, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 26, 2022 | DNA sequence analysis of the TTC21B gene demonstrated a sequence change, c.2161A>C, in exon 16 that results in an amino acid change, p.Asn721His. This sequence change does not appear to have been previously described in individuals with TTC21B-related. This sequence change has been described in the gnomAD database with a frequency of 0.44% in the African subpopulation and 0.042% in the overall population (dbSNP rs146637219). The p.Asn721His change affects a poorly conserved amino acid residue located in a domain of the TTC21B protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Asn721His substitution. Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Asn721His change remains unknown at this time. - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Jeune thoracic dystrophy;C0687120:Nephronophthisis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 17, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 08, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at